Consumer Staples

PepsiCo’s 2026 stock outlook: $157.01, modest 1.53% gain amid volatile institutional trading, strong brand and China expansion, yet geopolitical and safety concerns add risk for investors.

Clorox (CLX) trading sees mixed institutional moves, rising analyst targets up to $132, and Deutsche Bank warns of margin pressure—could $125‑$132 be in reach?

Discover how FUNR’s natural fruit‑juice strategy fuels health‑conscious consumers while revealing the volatility of the OTC beverage market.

Dogecoin Cash Inc’s crypto‑branded stock faces volatility, but its herbal personal‑care business offers stability. Learn how the firm can diversify, cut costs, and reposition for resilient growth in a shifting market.

Vital Farms stock dips amid class‑action lawsuits and analyst target cuts – yet strong brand equity and a low P/E suggest a potential upside for patient investors.

Angel Yeast Co. Ltd. raises full‑year earnings outlook, boosts investor transparency, and outlines growth plans amid China’s supportive food‑sector backdrop.

FFI Holdings Ltd

Bonk Inc’s 2025 10‑K reveals a bold pivot from health drinks to plant‑based energy and DeFi, with a reverse split, new CFO, and fresh growth strategy.

Read Lamb Weston’s Q3 earnings: a sharp $54M net income hit, margin squeeze, yet a revised 2026 sales outlook lifts investor confidence – see details.

Discover how Keurig Dr Pepper’s takeover of JDE Peet’s creates a global coffee powerhouse, led by new CEO Rafael Oliveira, boosting growth and margins worldwide.